Loading clinical trials...
Loading clinical trials...
The overall objective of this study is to determine if Vapotherm high flow nasal cannula therapy (HFT), when used to treat respiratory failure in the ED, is at least equivalent to the current standard...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Vapotherm, Inc.
Collaborators
NCT06213168 · De Novo Hypoxemic Acute Respiratory Failure (hARF)
NCT06189924 · Acute Respiratory Failure, Critical Illness
NCT06307392 · Acute Respiratory Failure Requiring Intubation
NCT06989385 · Acute Respiratory Failure
NCT05423301 · Acute Respiratory Failure
Athens Regional Medical Center
Athens, Georgia
McLeod Regional Medical Center
Florence, South Carolina
Erlanger Health System
Chattanooga, Tennessee
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions